Skip to main content
AmigoFish

Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments

From Pharmaceutical Executive · · 2 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay Pharmaceuticals, and Rafaat Rahmani argues that the costliest competitive intelligence failure is missing the moment a strategic assumption goes wrong.

Back to Pharmaceutical Executive · Report a problem